Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-05 @ 6:03 PM
Study NCT ID:
NCT02932267
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2016-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-11
First Submit QC Date:
None
Study First Post Date:
2016-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-26
Results First Submit QC Date:
None
Results First Post Date:
2019-11-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-16
Last Update Post Date:
2021-02-18
Last Update Post Date Type:
ACTUAL